The delivery of implantable cardioverter defibrillator (ICD) therapy is sophisticated and
requires the programming of over 100 settings. Physicians tailor these settings with the …

Background Emerging interest is seen in the paradox of defibrillator shocks for ventricular
tachyarrhythmia and increased mortality risk. Particularly in patients with dilated …

Background Large‐scale studies describing modern populations using an implantable
cardioverter‐defibrillator (ICD) are lacking. We aimed to analyze the incidence of arrhythmia …

Background Contemporary guideline-directed medical therapy (GDMT) confers a significant
mortality benefit for patients with heart failure with reduced ejection fraction (HFrEF), as …

Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …

(ICDs) play a crucial role in the treatment of patients at heightened risk of sudden cardiac
death (SCD) caused by ventricular arrhythmias. The use of ICDs for primary prevention is …

Background In at-risk patients with left ventricular dysfunction, implantable cardioverter
defibrillators (ICDs) prolong life. Implantable cardioverter defibrillators are increasingly …

The purpose of this study was to evaluate predictors of appropriate therapy in patients with
implantable cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death …

Aims Atrial fibrillation (AF) is often present in patients with left ventricular dysfunction who
receive an implantable cardioverter-defibrillator (ICD). The purpose of this study was to …

Background A 10-J energy safety margin has traditionally been used in programing
implantable cardioverter defibrillators (ICDs). The Low Energy Safety Study (LESS) tests the …